Xuebijing injection for sepsis patients in real-world settings
Part of Infections clinical trials.
This trial tests whether Xuebijing injection improves outcomes for adults with sepsis. It looks at how well the treatment works in everyday hospital care, not just in a controlled research setting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently hospitalized.
- You have been diagnosed with sepsis according to current medical guidelines.
- You or your legal representative can sign a consent form.
- You have not had sepsis before this episode.
- Your sepsis diagnosis was made within the last 48 hours.
- You are not currently in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the outcomes of people hospitalized with sepsis in China. It helps doctors understand how patients respond to treatment and what factors affect recovery.
This trial tests if Shenhuang granules, a traditional Chinese medicine, can help treat sepsis (a life-threatening response to infection). It aims to see if it improves outcomes for patients with sepsis.
This trial tests whether Shenfu injection can improve the flexibility of blood vessels in people with severe infections (sepsis or septic shock). It may help understand how to better support the heart and circulation during critical illness.
This study looks at a Chinese herbal injection called Xuebijing to see if certain biomarkers can predict how well it works for sepsis patients. It may help find new ways to treat sepsis more effectively.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study tests a new, timely approach to managing sepsis (a severe infection that can harm the body). It aims to improve care in the Emergency Department and Intensive Care Unit, which could help patients recover faster.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.